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Summary
 
Using H-2K
 
d
 
-restricted photoprobe-specific cytotoxic T lymphocyte (CTL) clones, which
permit assessment of T cell receptor (TCR)-ligand interactions by TCR photoaffinity labeling,
we observed that the efficiency of antigen recognition by CTL was critically dependent on the
half-life of TCR-ligand complexes. We show here that antigen recognition by CTL is essen-
tially determined by the frequency of serial TCR engagement, except for very rapid dissociations,
which resulted in aberrant TCR signaling and antagonism. Thus agonists that were efficiently
recognized exhibited rapid TCR–ligand complex dissociation, and hence a high frequency of
serial TCR engagement, whereas the opposite was true for weak agonists. Surprisingly, these
differences were largely accounted for by the coreceptor CD8. While it was known that CD8
substantially decreases TCR–ligand complex dissociation, we observed in this study that this
effect varied considerably among ligand variants, indicating that epitope modifications can alter
the CD8 contribution to TCR-ligand binding, and hence the efficiency of antigen recognition
by CTL.
M
 
odifications of antigenic peptides can affect CTL re-
sponses in a diverse manner, such as provoking either
antagonism, weak or strong responses or selective activa-
tion of Fas (CD95/APO-1) dependent cytotoxicity (1–4).
As to the mechanism, it has been shown that TCR antago-
nists provoke hypophosphorylation of CD3 
 
j
 
 chains, which
fail to recruit and activate the tyrosine kinase ZAP-70, thus
impairing the ZAP-70–NFAT pathway of T cell activation
(1, 5–7). Two main hypotheses have been proposed to ex-
plain these phenomena. First, ligand modification may re-
sult in accelerated dissociation of TCR-ligand complexes
and thus perturb the cascade of biochemical events that is
initiated by TCR-ligation (8–10). Alternatively, ligand
modification may confer, via conformational changes in
TCR, qualitative changes in signaling by TCR-associated
molecules (11, 12).
The observation that blocking of CD8, or in the case of
T helper cells CD4, can convert weak peptide agonists into
antagonists (7, 13, 14), indicated that the way T cells per-
ceive antigen is determined in part by the coreceptor. Since
coreceptors are associated with the cytoplasmic tyrosine ki-
nase p56
 
lck
 
, which plays a key role in T cell activation, it
has been proposed that the particular pattern of TCR sig-
naling seen using partial agonists and antagonists is the re-
sult of inefficient recruitment of coreceptor to TCR (7). On
the other hand, it has been shown that CD8, by coordinate
binding of MHC molecules that interact with TCR, signif-
icantly strengthens the avidity of TCR-ligand binding by
decreasing the dissociation of TCR-ligand complexes (15,
16). The intimate participation of CD8 in TCR-ligand in-
teractions raises the question whether CD8 may play a role
in aberrant CTL function by modulating the dynamics of
TCR-ligand interactions.
To assess TCR-ligand binding and its dependence on
CD8, we used H-2K
 
d
 
-restricted CTL clones that are spe-
cific for a photoreactive peptide derivative and thus permit
measurement of TCR-ligand interactions by TCR photo-
affinity labeling (4, 15, 17). To this end the 
 
Plasmodium
berghei
 
 circumsporozoite peptide PbCS 252-260 (SYIP-
SAEKI) was modified by replacing PbCS S-252 with iodo-
4-azidosalicylic acid (
 
IASA
 
) and conjugating PbCS K-259
with 4-azidobenzoic acid (
 
ABA
 
). Selective photoactivation
of the 
 
IASA
 
 group permitted covalent attachment of the
conjugate to K
 
d
 
 and photoactivation of the 
 
ABA
 
 group to
TCR. By testing 12 peptide derivative variants on 7 CTL
clones, we have previously identified 12 cases for which the
efficiency of antigen recognition (cytotoxicity) and TCR-
ligand binding (TCR photoaffinity labeling) diverged by
five-fold or more (4). As these divergences often did not
correlate with the avidity of TCR-ligand binding, we ex-
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amine here whether they are related to the dissociation
rates of TCR-ligand complexes and how these depend on
the coreceptor CD8.
 
Materials and Methods
 
Chromium Release Assay.
 
The generation of the 
 
IASA
 
-YIP-
SAEK(
 
ABA
 
)I-specific CTL clones S4, S14, S17, and T1 and their
culture conditions have been described previously (4, 17). Anti-
genic activities of peptide derivatives were determined in a 
 
51
 
Cr-
release assay as described (4, 17). In brief, 
 
51
 
Cr-labeled P815 cells
(2 
 
3
 
 10
 
3
 
 per well) were incubated in DMEM supplemented with
FCS (5%) and Hepes (10 mM) with 10-fold dilutions of peptide
derivative ranging from 10
 
2
 
6
 
–10
 
2
 
13
 
 M. Cloned CTL (6 
 
3
 
 10
 
3
 
per well) were added and after 4 h of incubation at 37
 
8
 
C the 
 
51
 
Cr
content of supernatants was determined. The specific lysis was cal-
culated as 100 
 
3
 
 (experimental
 
2
 
spontaneous release)/(total
 
2
 
spontaneous release). The relative antigenic activities were calcu-
lated by dividing the concentrations of 
 
IASA
 
-YIPSAEK(
 
ABA
 
)I
required for half-maximal lysis by that required for the variant
peptide derivatives. For sake of comparison the relative antigenic
activities of the compounds were normalized by dividing by the
relative K
 
d
 
 competitor activity, which expresses the ability of a
peptide derivative to bind to K
 
d
 
 (4, 17). In experiments where
Fab
 
9
 
 fragments of the anti-K
 
d
 
 
 
a
 
3 mAb SF1-1.1.1 were used, and
in the antagonist assays, the peptide derivatives were covalently
attached to P815 cell-associated K
 
d
 
 (see below).
 
Interferon 
 
g
 
 Assay.
 
The CTL were incubated with sensitized
target cells under the same conditions as for the cytotoxic assay,
except that peptide derivative concentrations ranged from 10
 
2
 
6
 
–
10
 
2
 
11
 
 M. After 24 h incubation the IFN-
 
g
 
 content in superna-
tants was assessed by ELISA as previously described (18).
 
K
 
d
 
 Photoaffinity Labeling.
 
Synthesis and photoaffinity-labeling
procedures were performed essentially as described (4, 17, 19). In
brief, for photoaffinity labeling of cell-associate K
 
d
 
 molecules,
P815 mastocytoma cells were incubated with the respective pep-
tide derivatives for 60 min at 37
 
8
 
C, followed by UV irradiation at
 
>
 
350 nm. Preparation of 
 
125
 
I-labeled soluble covalent K
 
d
 
-peptide
derivative complexes was performed as described (4). The stock
solutions had concentrations of 1–5 
 
3
 
 10
 
8
 
 cpm/ml and specific
radioactivities of 
 
z
 
2,000 Ci/mMol.
 
TCR Photoaffinity Labeling.
 
TCR photoaffinity labeling was
performed as described (4, 15, 17, 19), except that the samples
were incubated at 26
 
8
 
C for 30–60 min before UV irradiation at
312 
 
6
 
 40 nm. For TCR-ligand complex dissociation experi-
ments CTL (6 
 
3
 
 10
 
6
 
–2 
 
3
 
 10
 
7
 
 cells/ml) were preincubated in me-
dium with 
 
125
 
I-labeled K
 
d
 
-peptide derivatives complexes (1–6 
 
3
 
10
 
7
 
 cpm/ml for 90–150 min at 0–4
 
8
 
C or for 30–60 min in me-
dium containing SF1-1.1.1 Fab
 
9
 
 (20 
 
m
 
g/ml). Aliquots (100–700 
 
m
 
l)
were added to 10-ml volumes of 26
 
8
 
C medium containing 0.7%
FCS and anti-K
 
d
 
 
 
a
 
1 mAb 20-8-4S (10 
 
m
 
g/ml), which prevents
TCR-ligand binding (15), and incubated at 26
 
8
 
C for the indi-
cated periods. After UV irradiation for 20 s with a 500 W UV B
lamp (Dr. Hönle Inc., Munich, Germany, equipped with an in-
frared and an UV 296-nm filter), TCR were immunoprecipitated
and analyzed by SDS-PAGE. TCR photoaffinity labeling was quan-
tified by phosphor-imaging and normalized relative to the wild-
type as described (4). Mean values and standard deviations were
calculated from three to six independent experiments.
 
TCR-ligand Binding.
 
TCR-ligand binding was determined
by a direct binding assay as previously described (4), except that
the incubations of CTL (1.2 
 
3
 
 10
 
6
 
 cells/200 
 
m
 
l) with 
 
125
 
I-labeled
K
 
d
 
-peptide derivative complexes (3–10 
 
3
 
 10
 
6
 
 cpm/incubation)
were performed for 30–60 min at 26
 
8
 
C. Specific TCR-ligand
binding was calculated by subtracting from the total cell-associ-
ated cpm, the cpm measured in presence of anti-K
 
d
 
 mAb 20-8-4S
(10 
 
m
 
g/ml). The specific binding (cpm) for the wild-type (wt)
ligand for a given clone was referred to as 1 and the binding of
the variant ligands expressed relative to this value. Due to high
background the difference between TCR-ligand binding in the
presence and absence of SF1-1.1.1 Fab
 
9
 
 was assessed by TCR
photoaffinity labeling. Each experiment was performed in tripli-
cates and repeated at least twice.
 
Results and Discussion
 
To assess the significance of TCR-ligand complex disso-
ciation for CTL function, we selected two cases, in which
antigen recognition was more efficient than TCR-ligand
binding (strong agonists) (peptide derivative variant P255A
on T1 CTL and S256A on S17 CTL) and two examples
where recognition was less efficient than binding (weak ag-
onists) (P255S on S17 CTL and E258A on S14 CTL) (Fig.
1 
 
a
 
). Since perforin dependent cytotoxicity, as mainly as-
sessed in the used chromium release assay, is a rapid CTL
response and takes place at very low peptide concentrations
(20, 21), we also assessed the interferon-
 
g
 
 (IFN-
 
g
 
) response,
which requires higher peptide concentrations and sustained
TCR signaling for extended periods of time (21). In spite
of these differences both CTL responses were remarkably
similar, except that on S14 CTL for E258A the IFN-
 
g
 
 pro-
duction was more efficient than cytotoxicity (Fig. 1 
 
b
 
). Oc-
casional divergences between cytolytic and IFN-
 
g
 
 CTL re-
sponses among peptide variants have also been observed in
other systems (24).
Assessment of the kinetics of TCR-ligand complex dis-
sociation showed that for both strong agonists the dissocia-
tion was significantly faster than for the wild-type ligand
(Fig. 2, 
 
a
 
 and 
 
c
 
). In contrast, for the two weak agonists dis-
sociation was markedly slower, even though in one case
(E258A on S14 CTL) TCR-ligand binding was weak (Fig.
2, 
 
b
 
 and 
 
c
 
). For sake of increased accuracy, these kinetics
were assessed at 26
 
8
 
C. With S17 CTL kinetics were also
measured at 37
 
8
 
C (Fig. 2 
 
d
 
), showing that on living CTL
TCR-ligand complex dissociation increases considerably
with temperature, as has been reported for T1 CTL (15).
These findings are consistent with the concept of serial TCR
engagement (21, 23, 24), namely that CTL activation de-
pends on the frequency of serial TCR engagement, which
is determined by the rate of TCR-ligand complex dissocia-
tion.
To test this hypothesis, we repeated these experiments in
the presence of Fab
 
9
 
 fragments of the anti-K
 
d
 
 
 
a
 
3 mAb SF1-
1.1.1, which prevents participation of CD8 in TCR-ligand
binding, but not CD8 dependent adhesion (15). Remark-
ably, in the presence of this reagent the efficiency of antigen
recognition (cytotoxicity) was often unchanged or even in-
creased (Fig. 1 
 
a
 
). This was also true for IFN-
 
g
 
 production;
indeed, in two instances blocking of CD8 substantially in-
creased this response (wt and P255S on S17 CTL) (Fig. 1 
 
b
 
).
However in other cases SF1-1.1.1 Fab
 
9
 
 dramatically re-
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duced the cytotoxic or IFN-
 
g
 
 response (P255A on T1, wt
and E258A on S14 CTL) (Fig. 1). With the exception of
the latter cases, blocking of CD8 reduced TCR-ligand bind-
ing more than it decreased the efficiency of antigen recog-
nition, as a result the efficiency of antigen recognition was
increased relative to TCR-ligand binding; i.e., agonists or
weak agonists were converted into strong agonists (Fig. 1).
TCR-ligand complex dissociation was always considerably
faster in the presence of SF1-1.1.1 Fab
 
9
 
 than in its absence
(Fig. 2). This is consistent with reports showing that CD8
stabilizes TCR-ligand binding by decreasing dissociation of
TCR-ligand complexes (15, 16). Our finding that accelera-
tion of TCR-ligand complex dissociation increased the rel-
ative efficiency of antigen recognition supports the concept
that CTL activation depends on the frequency of serial
Figure 1. Antigen recognition, IFN-g production and TCR-ligand
binding for IASA-YIPSAEK(ABA)I (wt) and variants on cloned CTL.
The normalized relative antigenic activities (cytotoxicity) and TCR-
ligand binding at 268C are shown as open and full bars, respectively (a),
and the IFN-g production as open bars (b). All values were normalized
relative to IASA-YIPSAEK(ABA)I. The cases for which the CTL re-
sponse was >5-fold lower than TCR-ligand binding are shown in red
and those for which it was >5-fold higher in green. TCR antagonists are
shown in purple. The variants tested include IASA-YIASAEK(ABA)I
(P255A), IASA-YIPSAAK(ABA)I (E258A), IASA-YISSAEK(ABA)I
(P255S), IASA-YIPAAEK(ABA)I (S256A), IASA-YILSAEK(ABA)I
(P255L), and the CTL clones T1, S14, and S17. Some of the experiments
were performed in the presence of SF1-1.1.1 Fab9. Each experiment was
performed in triplicates and the mean values and standard deviations were
calculated from at least two experiments.
Figure 2. TCR-ligand complex dissociation kinetics on cloned T1,
S17 and S14 CTL. Aliquots of CTL, preincubated in the absence or pres-
ence of SF1.-1.1.1 Fab9 with soluble covalent complexes of Kd and
IASA-YIPSAEK(ABA)I or variants, were diluted into aliquots of DMEM
containing anti-Kd a1 mAb 20-8-4S and UV irradiated after the indicated
periods of incubation. All kinetic experiments were performed at 268C,
except the one shown in d, which was assessed at 378C. The TCR photo-
affinity labeling observed at time 0 was defined as 100%. t1/2 designates
the time required for 50% dissociation.
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TCR engagement. It has been reported that CD8 expres-
sion on CTL can be downmodulated by antigen (25, 26),
which is likely to have similar effects as the CD8 blocking
experiments described here.
Exceptions to this rule were the cases where blocking of
CD8 participation in TCR-ligand binding dramatically im-
paired antigen recognition. As it has been shown that block-
ing of CD4 can convert agonists into antagonists (7, 13), we
examined whether, in the presence of SF1-1.1.1 Fab9, the
variants P255A and E258A antagonized the cytotoxic re-
sponses of T1 and S14 CTL, respectively. As shown in Fig.
3, this was indeed the case. In the presence of this reagent
the recognition of IASA-YIPSAEK(ABA)I by T1 (Fig. 3 a)
and S14 CTL (Fig. 3 b) was significantly reduced on target
cells that expressed covalent Kd-P255A or Kd-S256A com-
plexes, compared to target cells that expressed irrelevant
Kd-P255H complexes (4). Consistent with these findings
we observed in both cases predominant pp21 j chain phos-
phorylation in the presence, but not in the absence of SF1-
1.1.1 Fab9 (data not shown). This form of j chain phos-
phorylation has been shown to be preferentially or exclu-
sively induced by TCR antagonists (1, 5–7). Remarkably,
in both cases exceedingly fast TCR-ligand complex disso-
ciations were observed (Fig. 2, e and f). The only other
comparably fast dissociation was recorded for variant P255L
on S14 CTL, which is an antagonist for this clone (Fig. 2 b
and reference 4). These observations are in agreement with
the kinetic proofreading concept (8, 9) and a study by Ly-
ons et al. (10) demonstrating that TCR-ligand complex
dissociation is more rapid for antagonists than for agonists.
Taken collectively our findings indicate that acceleration of
TCR-ligand complex dissociation increases the efficiency
of antigen recognition by CTL up to a critical threshold,
beyond which TCR engagement results in aberrant TCR
signaling and TCR antagonism.
It is interesting to note that the half-life of TCR-ligand
complexes varied considerably among different CTL clones
(Fig. 2, a–c), which may explain why certain CTL clones
are more prone to TCR antagonism than others (4). For
example with S17 CTL, which exhibited remarkably slow
dissociation kinetics, TCR antagonism was never observed,
even when testing large panels of epitope variants, whereas
the opposite was true for S14 CTL and, to a lesser extent,
T1 CTL, especially in the presence of SF1-1.1.1 Fab9(Figs.
1 and 2, reference 4 and unpublished data).
A striking finding of our study is that the contribution of
CD8 to TCR-ligand binding varied not only among CTL
clones, but also among epitope variants on given clones (Fig.
4 a). While the former differences can be explained in part
by variations in CD8 and TCR expression (Fig. 4 a), the
latter indicate that epitope modifications can alter the avidity
of CD8 participation in TCR-ligand binding. This explains,
at least in part, why blocking of CD8 accelerated TCR-
ligand complex dissociation in a diverse manner, and why
one cannot reliably predict from the avidity of TCR-ligand
binding the dissociation rates and hence the functional phe-
Figure 3. Blocking of CD8 converts agonists P255A and S256A into
antagonists for T1 and S14 CTL, respectively. T1 (a) or S14 CTL (b)
were incubated in the presence of IASA-YIPSAEK(ABA)I 1029 M in (a),
1027 M in (b) and SF1-1.1.1 Fab9 (20 mg/ml) with 51Cr-labeled P815
cells, expressing Kd molecules crosslinked with variant P255A, 1029 M (a)
or E258A, 1028 M (b) or P255H, 1029 M in a and 1028 M in b, a deriva-
tive not recognized by either TCR (4). The mean values and standard devia-
tions were calculated from triplicate values of a representative experiment.
Figure 4. Epitope modifications alter the contribution of CD8 to
TCR-ligand binding. The degree of CD8 participation in TCR-ligand
binding is expressed as the ratio of TCR-ligand binding in the absence,
divided by the binding in the presence of SF1-1.1.1 Fab9 (a). The surface
expression of TCR and CD8 was assessed by flow cytometry after stain-
ing with antibodies H57-597 and H35-17, respectively. The values indi-
cate mean fluorescence intensities for a representative experiment. (b) Dif-
ferent ligand variants exhibit different ratios of TCR-a versus -b chain
TCR photoaffinity labeling on T1 and S17 CTL. An autoradiogram of
SDS-PAGE (10%, reducing conditions) of a representative experiment is
shown.
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notype of epitope variants (Figs. 1 and 2 and reference 4).
Moreover, several ligand variants displayed different ratios
of TCR a versus b chain photoaffinity labeling (Fig. 4 b).
Similar findings were obtained at 0–48C (unpublished data),
i.e., in the absence of metabolically active cellular processes,
suggesting that epitope modification can induce either con-
formational changes in TCR or slightly alter the orientation
of TCR-ligand binding, as a result of which CD8 may par-
ticipate more or less avidly in TCR-ligand binding. This
view is consistent with the observation that anti-TCR mAb
and their Fab9 can substantially affect T cell responses (11,
12), and suggests that the conformational changes induced by
such reagents, can affect T cell function by interfering with
TCR-coreceptor cooperation. It is also interesting to note
that TCR-ligand binding apparently can induce structural
changes in the a3 domain of MHC class I molecules,
which may alter their interaction with CD8 (27, 28).
The present study shows that the half-life of TCR-
ligand complexes is of critical importance for CTL activa-
tion and is determined to a considerable degree by the
coreceptor CD8. The finding that epitope modifications
can alter the participation of CD8 in TCR-ligand binding,
and hence TCR-ligand complex dissociation, reveals a new
principle by which CD8 can affect CTL function. How-
ever CD8 plays other roles in CTL function as well, such as
mediating CTL-target cell adhesion and participation in
CTL activation by CD8-dependent signaling (29, 30), which
must also be taken into account for a comprehensive un-
derstanding of the role of CD8 in normal and aberrant
CTL function.
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